Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Preclinical CRO Market Today And What Is Its Future Size?
The market size for preclinical contract research organizations (cro) has seen robust growth in the past few years. The projection is that it will expand from a value of $5.7 billion in 2024 to $6.25 billion in 2025, signaling a compound annual growth rate (CAGR) of 9.7%. The growth witnessed during the historic period is primarily attributed to the escalating demand for swift drug development, strategies for containing costs, prioritizing core competencies, adherence to regulatory compliance needs, and the internationalization of clinical trials.
Anticipations are high for significant expansion in the preclinical contract research organization (CRO) market size in the impending years. Its value is projected to accelerate to $8.99 billion by 2029, representing a compound annual growth rate (CAGR) of 9.5%. This expected growth within the forecast period is thought to be driven by factors such as the emergence of personalized medicine, increased focus on uncommon diseases and orphan drugs, a rise in biopharmaceuticals outsourcing, increased interest in biomarker research, and the need for real-world evidence generation. Critical trends to look out for within this period include the application of artificial intelligence (AI), the growth of oncology research, breakthroughs in omics technologies, progress in both in vitro and in vivo models, and partnerships geared towards translational research.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp
Which Key Factors Are Fueling Growth In The Preclinical CRO Market?
The surge in preclinical trials need is predicted to boost the progression of the preclinical CRO market in the future. Preclinical trials are studies carried out on a cure or medicine for a certain ailment prior to involving human subjects for testing. These preclinical studies frequently focus on new medical apparatus, prescribed drugs, and diagnostic methods. The primary goals are to establish a safe initial dose for first-in-human research and gauge the product’s potential toxicity. Significant in the drug development process, preclinical trials are increasingly valued due to the heightened stress on the safety and efficacy of new drugs. An example is in February 2024, where IQVIA, an American company known for its services in health information technology and clinical research reports, stated that there was an increase in clinical development productivity in 2023. A total of 69 unique active substances (NASs) were globally launched in 2023, which was 6 more from the previous year. Additionally, it also included 24 first-in-class launches in the U.S. This rising need for preclinical trials is therefore fuelling the advancement of the preclinical CRO market moving forward.
How Is The Preclinical CRO Market Segmented Across Key Categories?
The preclinical cromarket covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services
2) By Type: Patient Derived Organoid (PDO) Model; Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model; Large Animal Model
4) By Model System: In Vivo; In Vitro
5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-users
Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies; Pharmacodynamics Studies; Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing; Chronic Toxicity Testing; Reproductive Toxicity Testing
3) By Compound Management: Sample Management; Inventory Management; Formulation Services
4) By Chemistry: Medicinal Chemistry; Analytical Chemistry; Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies; Central Nervous System Safety Studies; Respiratory Safety Studies
6) By Other Services: Regulatory Consulting; Project Management; Data Management Services
What Key Trends Are Driving Growth In The Preclinical CRO Market?
The uptake of modern technology is a key trend emerging within the preclinical CRO market. Many leading firms in the preclinical CRO landscape are leveraging new-tech to maintain their market foothold. For instance, BenchSci, a leading Canadian AI solutions provider for preclinical R&D, rolled out ASCEND, a comprehensive SaaS platform dedicated to preclinical drug discovery, in February 2023. The platform aims to hasten drug development in the preclinical stage by developing a deeper understanding of the basic biological aspects of diseases. Using BenchSci’s AI technology, ASCEND pulls experimental information from both secure internal and publicly available external sources. The platform then contrasts these experimental findings using carefully compiled ontology datasets. Consequently, it can generate a map presenting the biological functions underlying various diseases, which is rooted in concrete evidence.
Who Are The Leading Companies Driving The Preclinical CRO Market?
Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report
Which Region Dominates The Preclinical CRO Market Today?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp
Browse Through More Reports Similar to the Global Preclinical CRO Market 2025, By The Business Research Company
Streaming Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/streaming-analytics-global-market-report
Content Streaming Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/content-streaming-global-market-report
Ott Streaming Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ott-streaming-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model